hsa-mir-5694: Hsa-mir-5694 is a miRNA that has been identified as strongly binding the AF9 mRNA 3' UTR and being significantly upregulated in breast cancer [PMC7934584]. In a study examining miRNA correlations, hsa-mir-5694 was found to have a strong inhibitory effect on PBK expression in MESO [PMC8632063]. Additionally, hsa-mir-5694, along with hsa-miR-5582-5p, hsa-miR-6745, and hsa-miR-374a-3p, has the ability to bind to the spike coding region of the SARS-CoV-2 genome [PMC9773347]. In the context of T1D, hsa-mir-5694 was identified as one of several miRNAs involved in target gene regulation [PMC8028841]. Specifically, it was found to target IGF2R along with 139 other miRNAs [PMC8028841]. Furthermore, several other genes and miRNAs were identified as potential biomarkers associated with T1D development including PRKACA, DSP, FOXD1, EYA1, TFAP2A, and GAB2 [PMC8028841]. The specific number of miRNAs targeting each gene is listed in Table 6 of the study [PMC8028841].